Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Journal of Gastroenterology
Published in: Clinical Journal of Gastroenterology 5/2015

01-10-2015 | Clinical Review

Gastrointestinal symptoms and disorders in patients with eating disorders

Authors: Yasuhiro Sato, Shin Fukudo

Published in: Clinical Journal of Gastroenterology | Issue 5/2015

Login to get access

Abstract

The two most clinically serious eating disorders are anorexia nervosa and bulimia nervosa. A drive for thinness and fear of fatness lead patients with anorexia nervosa either to restrict their food intake or binge-eat then purge (through self-induced vomiting and/or laxative abuse) to reduce their body weight to much less than the normal range. A drive for thinness leads patients with bulimia nervosa to binge-eat then purge but fail to reduce their body weight. Patients with eating disorders present with various gastrointestinal disturbances such as postprandial fullness, abdominal distention, abdominal pain, gastric distension, and early satiety, with altered esophageal motility sometimes seen in patients with anorexia nervosa. Other common conditions noted in patients with eating disorders are postprandial distress syndrome, superior mesenteric artery syndrome, irritable bowel syndrome, and functional constipation. Binge eating may cause acute gastric dilatation and gastric perforation, while self-induced vomiting can lead to dental caries, salivary gland enlargement, gastroesophageal reflux disease, and electrolyte imbalance. Laxative abuse can cause dehydration and electrolyte imbalance. Vomiting and/or laxative abuse can cause hypokalemia, which carries a risk of fatal arrhythmia. Careful assessment and intensive treatment of patients with eating disorders is needed because gastrointestinal symptoms/disorders can progress to a critical condition.
Literature
1.
Psychiatric Association, A.P.A.D.-T.F., Diagnostic and statistical manual of mental disorders : DSM-5. 2013, Washington, DC: American Psychiatric Pub
2.
Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 2003;34(4):383–96.PubMedCrossRef
3.
Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68(7):724–31.PubMedCrossRef
4.
O’Brien KM, Vincent NK. Psychiatric comorbidity in anorexia and bulimia nervosa: nature, prevalence, and causal relationships. Clin Psychol Rev. 2003;23:57–74.PubMedCrossRef
5.
Fassino S, Pieró A, Daga GA, Leombruni P, Mortara P, Rovera GG. Attentional biases and frontal functioning in anorexia nervosa. Int J Eat Disord. 2002;31(3):274–83.PubMedCrossRef
6.
Tchanturia K, Davies H, Roberts M, et al. Poor cognitive flexibility in eating disorders: examining the evidence using the Wisconsin Card Sorting Task. PLoS ONE. 2012;7(1):e28331.PubMedCentralPubMedCrossRef
7.
8.
Cavedini P, Bassi T, Ubbiali A, et al. Neuropsychological investigation of decision-making in anorexia nervosa. Psychiatry Res. 2004;127(3):259–66.PubMedCrossRef
9.
Tchanturia K, Liao PC, Uher R, et al. An investigation of decision making in anorexia nervosa using the Iowa Gambling Task and skin conductance measurements. J Int Neuropsychol Soc. 2007;13(4):635–41.PubMedCrossRef
10.
Kaye WH, Wierenga CE, Knatz S, et al. Temperament-based treatment for anorexia nervosa. Eur Eat Disord Rev. 2015;23(1):12–8.PubMedCrossRef
11.
Salvioli B, Pellicciari A, Iero L, et al. Audit of digestive complaints and psychopathological traits in patients with eating disorders: a prospective study. Dig Liver Dis. 2013;45(8):639–44.PubMedCrossRef
12.
Holt S, Ford MJ, Grant S, Heading RC. Abnormal gastric emptying in primary anorexia nervosa. Br J Psychiatry. 1981;139:550–2.PubMedCrossRef
13.
14.
Chami TN, Andersen AE, Crowell MD, et al. Gastrointestinal symptoms in bulimia nervosa: effects of treatment. Am J Gastroenterol. 1995;90(1):88–92.PubMed
15.
Chial HJ, McAlpine DE, Camilleri M. Anorexia nervosa: manifestations and management for the gastroenterologist. Am J Gastroenterol. 2002;97(2):255–69.PubMedCrossRef
16.
Drossman DA, Corazziari E, Delvaux M, et al. ROME III, the Functional Gastrointestinal Disorders, 3rd edn. McLean: Degnon Associates Inc; 2006.
17.
Wang X, Luscombe GM, Boyd C, et al. Functional gastrointestinal disorders in eating disorder patients: altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol. 2014;20(43):16293–9.PubMedCentralPubMed
18.
Stacher G, Kiss A, Wiesnagrotzki S, et al. Oesophageal and gastric motility disorders in patients categorised as having primary anorexia nervosa. Gut. 1986;27(10):1120–6.PubMedCentralPubMedCrossRef
19.
Benini L, Todesco T, Frulloni L, et al. Esophageal motility and symptoms in restricting and binge-eating/purging anorexia. Dig Liver Dis. 2010;42(11):767–72.PubMedCrossRef
20.
21.
Nickl NJ, Brazer SR, Rockwell K, Smith JW. Patterns of esophageal motility in patients with stable bulimia. Am J Gastroenterol. 1996;91(12):2544–7.PubMed
22.
Santonicola A, Siniscalchi M, Capone P, et al. Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol. 2012;18(32):4379–85.PubMedCentralPubMedCrossRef
23.
Boyd C, Abraham S, Kellow J. Psychological features are important predictors of functional gastrointestinal disorders in patients with eating disorders. Scand J Gastroenterol. 2005;40(8):929–35.PubMedCrossRef
24.
Dubois A, Gross HA, Ebert MH, Castell DO. Altered gastric emptying and secretion in primary anorexia nervosa. Gastroenterology. 1979;77(2):319–23.PubMed
25.
McCallum RW, Grill BB, Lange R, et al. Definition of a gastric emptying abnormality in patients with anorexia nervosa. Dig Dis Sci. 1985;30(8):713–22.PubMedCrossRef
26.
Abell TL, Malagelada JR, Lucas AR, et al. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology. 1987;93(5):958–65.PubMed
27.
Rigaud D, Bedig G, Merrouche M, et al. Delayed gastric emptying in anorexia nervosa is improved by completion of a renutrition program. Dig Dis Sci. 1988;33(8):919–25.PubMedCrossRef
28.
Robinson PH, Clarke M Barrett, J. Determinants of delayed gastric emptying in anorexia nervosa and bulimia nervosa. Gut, 1988. 29(4): p. 458-64.
29.
Zipfel S, Sammet I, Rapps N, et al. Gastrointestinal disturbances in eating disorders: clinical and neurobiological aspects. Auton Neurosci. 2006;129(1–2):99–106.PubMedCrossRef
30.
Walsh BT, Zimmerli E, Devlin MJ, et al. A disturbance of gastric function in bulimia nervosa. Biol Psychiatry. 2003;54(9):929–33.PubMedCrossRef
31.
Devlin MJ, Kissileff HR, Zimmerli EJ, et al. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent. Physiol Behav. 2012;106(2):238–42.PubMedCentralPubMedCrossRef
32.
Zimmerli EJ, Walsh BT, Guss JL, et al. Gastric compliance in bulimia nervosa. Physiol Behav. 2006;87(2):441–6.PubMedCrossRef
33.
Russell DM, Freedman ML, Feiglin DH, et al. Delayed gastric emptying and improvement with domperidone in a patient with anorexia nervosa. Am J Psychiatry. 1983;140(9):1235–6.PubMedCrossRef
34.
Stacher G, et al. Gastric emptying, body weight and symptoms in primary anorexia nervosa. Long-term effects of cisapride. Br J Psychiatry. 1993;162:398–402.PubMedCrossRef
35.
Stacher G, Bergmann H, Wiesnagrotzki S, et al. Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosa. Gastroenterology. 1987;92(4):1000–6.PubMed
36.
Szmukler GI, Young GP, Miller G, et al. A controlled trial of cisapride in anorexia nervosa. Int J Eat Disord. 1995;17(4):347–57.PubMedCrossRef
37.
Domstad PA, Shih WJ, Humphries L, et al. Radionuclide gastric emptying studies in patients with anorexia nervosa. J Nucl Med. 1987;28(5):816–9.PubMed
38.
Adson DE, Mitchell JE, Trenkner SW. The superior mesenteric artery syndrome and acute gastric dilatation in eating disorders: a report of two cases and a review of the literature. Int J Eat Disord. 1997;21(2):103–14.PubMedCrossRef
39.
Elbadaway MH. Chronic superior mesenteric artery syndrome in anorexia nervosa. Br J Psychiatry. 1992;160:552–4.PubMedCrossRef
40.
Mathenge N, Osiro S, Rodriguez II. Superior mesenteric artery syndrome and its associated gastrointestinal implications. Clin Anat. 2014;27(8):1244–52.PubMedCrossRef
41.
Mansberger AR Jr, Hearn JB, Byers RM, et al. Vascular compression of the duodenum. Emphasis on accurate diagnosis. Am J Surg. 1968;115(1):89–96.PubMedCrossRef
42.
Verhoef PA, Rampal A. Unique challenges for appropriate management of a 16-year-old girl with superior mesenteric artery syndrome as a result of anorexia nervosa: a case report. J Med Case Rep. 2009;3:127.PubMedCentralPubMedCrossRef
43.
Vannatta JB, Cagas CR, Cramer RI. Superior mesenteric artery (Wilkie’s) syndrome: report of three cases and review of the literature. South Med J. 1976;69(11):1461–5.PubMedCrossRef
44.
Froese AP, Szmuilowicz J, Bailey JD. The superior-mesenteric-artery syndrome: cause or complication of anorexia nervosa?. Can Psychiatr Assoc J. 1978;23(5):325–7.PubMed
45.
Jordaan GP, Muller A, Greeff M, Stein DJ. Eating disorder and superior mesenteric artery syndrome. J Am Acad Child Adolesc Psychiatry. 2000;39(10):1211.PubMedCrossRef
46.
Szajnberg N. Eating disorder and superior mesenteric artery syndrome. J Am Acad Child Adolesc Psychiatry. 2001;40(4):388–9.PubMedCrossRef
47.
Lo DY, Yen JL, Jones MP. Massive gastric dilation and necrosis in anorexia nervosa: cause or effect?. Nutr Clin Pract. 2004;19(4):409–12.PubMedCrossRef
48.
Ikegaya H, Nakajima M, Shintani-Ishida K, et al. Death due to duodenal obstruction in a patient with an eating disorder: a case report. Int J Eat Disord. 2006;39(4):350–2.PubMedCrossRef
49.
Moreno MA, Smith MS. Anorexia in a 14-year-old girl: why won’t she eat?. J Adolesc Health. 2006;39(6):936–8.PubMedCrossRef
50.
Gwee K, Teh A, Huang C. Acute superior mesenteric artery syndrome and pancreatitis in anorexia nervosa. Australas Psychiatry. 2010;18(6):523–6.PubMedCrossRef
51.
Rehman A, et al. Wilkie’s syndrome. J Coll Physicians Surg Pak. 2011;21(1):43–5.PubMed
52.
Kornmehl P, Weizman Z, Liss Z, et al. Superior mesenteric artery syndrome presenting as an anorexia nervosa-like illness. J Adolesc Health Care. 1988;9(4):340–3.PubMedCrossRef
53.
Abraham S, Kellow JE. Do the digestive tract symptoms in eating disorder patients represent functional gastrointestinal disorders?. BMC Gastroenterol. 2013;13:38.PubMedCentralPubMedCrossRef
54.
Dejong H, Perkins S, Grover M, Schmidt U. The prevalence of irritable bowel syndrome in outpatients with bulimia nervosa. Int J Eat Disord. 2011;44(7):661–4.PubMedCrossRef
55.
Sileri P, Franceschilli L, De Lorenzo A, et al. Defecatory disorders in anorexia nervosa: a clinical study. Tech Coloproctol. 2014;18(5):439–44.PubMed
56.
Chiarioni G, Bassotti G, Monsignori A, et al. Anorectal dysfunction in constipated women with anorexia nervosa. Mayo Clin Proc. 2000;75(10):1015–9.PubMedCrossRef
57.
Chun AB, Sokol MS, Kaye WH, et al. Colonic and anorectal function in constipated patients with anorexia nervosa. Am J Gastroenterol. 1997;92(10):1879–83.PubMed
58.
Støving RK, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999;33(2):139–52.PubMedCrossRef
59.
Fragidis S, Sombolos K, Thodis E, et al. Low T3 syndrome and long-term mortality in chronic hemodialysis patients. World J Nephrol. 2015;4(3):415–22.PubMedCentralPubMedCrossRef
60.
Bello G, Ceaichisciuc I, Silva S, Antonelli M. The role of thyroid dysfunction in the critically ill: a review of the literature. Minerva Anestesiol. 2010;76(11):919–28.PubMed
61.
Kamal N, Chami T, Andersen A, et al. Delayed gastrointestinal transit times in anorexia nervosa and bulimia nervosa. Gastroenterology. 1991;101(5):1320–4.PubMed
62.
Hadley SJ, Walsh BT. Gastrointestinal disturbances in anorexia nervosa and bulimia nervosa. Curr Drug Targets CNS Neurol Disord. 2003;2(1):1–9.PubMedCrossRef
63.
Dreznik Z, Vishne TH, Kristt D, et al. Rectal prolapse: a possibly underrecognized complication of anorexia nervosa amenable to surgical correction. Int J Psychiatry Med. 2001;31(3):347–52.PubMedCrossRef
64.
Guerdjikova AI, O’Melia A, Riffe K, et al. Bulimia nervosa presenting as rectal purging and rectal prolapse: case report and literature review. Int J Eat Disord. 2012;45(3):456–9.PubMedCrossRef
65.
Malik M, Stratton J, Sweeney WB. Rectal prolapse associated with bulimia nervosa: report of seven cases. Dis Colon Rectum. 1997;40(11):1382–5.PubMedCrossRef
66.
Marceau C, Parc Y, Debroux E, et al. Complete rectal prolapse in young patients: psychiatric disease a risk factor of poor outcome. Colorectal Dis. 2005;7(4):360–5.PubMedCrossRef
67.
68.
Peters WA, Smith MR, Drescher CW, Rectal prolapse in women with other defects of pelvic floor support. Am J Obstet Gynecol, 2001. 184(7): p. 1488-94; discussion 1494-5.
69.
70.
Roig JV, Buch E, Alós R, et al. Anorectal function in patients with complete rectal prolapse. Differences between continent and incontinent individuals. Rev Esp Enferm Dig. 1998;90(11):794–805.PubMed
71.
De Caprio C, Alfano A, Senatore I, et al. Severe acute liver damage in anorexia nervosa: two case reports. Nutrition. 2006;22(5):572–5.PubMedCrossRef
72.
73.
Furuta S, Ozawa Y, Maejima K, et al. Anorexia nervosa with severe liver dysfunction and subsequent critical complications. Intern Med. 1999;38(7):575–9.PubMedCrossRef
74.
Sakada M, Tanaka A, Ohta D, et al. Severe steatosis resulted from anorexia nervosa leading to fatal hepatic failure. J Gastroenterol. 2006;41(7):714–5.PubMedCrossRef
75.
Tajiri K, Shimizu Y, Tsuneyama K. Sugiyama T.A case report of oxidative stress in a patient with anorexia nervosa. Int J Eat Disord. 2006;39(7):616–8.PubMedCrossRef
76.
Thelen MH, Mann LM, Pruitt J, Smith M. Bulimia: prevalence and component factors in college women. J Psychosom Res. 1987;31(1):73–8.PubMedCrossRef
77.
Connors ME, Johnson CL. Epidemiology of bulimia and bulimic behaviors. Addict Behav. 1987;12(2):165–79.PubMedCrossRef
78.
Russell GF. Acute dilatation of the stomach in a patient with anorexia nervosa. Br J Psychiatry. 1966;112(483):203–7.PubMedCrossRef
79.
80.
81.
Saul SH, Dekker A, Watson CG. Acute gastric dilatation with infarction and perforation. Report of fatal outcome in patient with anorexia nervosa. Gut, 1981. 22(11): p. 978-83.
82.
Abdu RA, Garritano D, Culver O. Acute gastric necrosis in anorexia nervosa and bulimia. Two case reports. Arch Surg. 1987;122(7):830–2.PubMed
83.
Reeve T, et al. Near-total gastric necrosis caused by acute gastric dilatation. South Med J. 1988;81(4):515–7.PubMedCrossRef
84.
Patocskai EJ, Thomas JM. Gastric necrosis in a patient with bulimia. Eur J Surg. 2002;168(5):302–4.PubMedCrossRef
85.
Glorio R, Allevato M, De Pablo A, et al. Prevalence of cutaneous manifestations in 200 patients with eating disorders. Int J Dermatol. 2000;39(5):348–53.PubMedCrossRef
86.
Mehler PS. Medical complications of bulimia nervosa and their treatments. Int J Eat Disord. 2011;44(2):95–104.PubMed
87.
88.
Kiss A, Wiesnagrotzki S, Abatzi TA, et al. Upper gastrointestinal endoscopy findings in patients with long-standing bulimia nervosa. Gastrointest Endosc. 1989;35(6):516–8.PubMedCrossRef
89.
Stacher G, Wiesnagrotzki S, Kiss A. Symptoms of achalasia in young women mistaken as indicating primary anorexia nervosa. Dysphagia. 1990;5(4):216–9.PubMedCrossRef
90.
91.
Richterich A, Brunner R. ReschF. Achalasia mimicking prepubertal anorexia nervosa. Int J Eat Disord. 2003;33(3):356–9.PubMedCrossRef
92.
Desseilles M, Fuchs S, Ansseau M, et al. Achalasia may mimic anorexia nervosa, compulsive eating disorder, and obesity problems. Psychosomatics. 2006;47(3):270–1.PubMedCrossRef
93.
Garcia Júnior C, Araújo OF, Murro AL, et al., Idiopathic achalasia mistakenly diagnosed as anorexia nervosa. Rev Bras Psiquiatr, 2008. 30(2): p. 168.
94.
Däbritz J, Domagk D, Monninger M, Foell D. Achalasia mistaken as eating disorders: report of two children and review of the literature. Eur J Gastroenterol Hepatol. 2010;22(7):775–8.PubMedCrossRef
95.
96.
Crow SJ, Salisbury JJ, Crosby RD, Mitchell JE. Serum electrolytes as markers of vomiting in bulimia nervosa. Int J Eat Disord. 1997;21(1):95–8.PubMedCrossRef
97.
98.
Romanos GE, Javed F, Romanos EB, Williams RC. Oro-facial manifestations in patients with eating disorders. Appetite. 2012;59(2):499–504.PubMedCrossRef
99.
Valena V, Young WG. Dental erosion patterns from intrinsic acid regurgitation and vomiting. Aust Dent J. 2002;47(2):106–15.PubMedCrossRef
100.
Mendell DA, Logemann JA. Bulimia and swallowing: cause for concern. Int J Eat Disord. 2001;30(3):252–8.PubMedCrossRef
101.
Mehler PS, Wallace JA. Sialadenosis in bulimia. A new treatment. Arch Otolaryngol Head Neck Surg. 1993;119(7):787–8.PubMedCrossRef
102.
Kinzl J, Biebl W, Herold M. Significance of vomiting for hyperamylasemia and sialadenosis in patients with eating disorders. Int J Eat Disord. 1993;13(1):117–24.PubMedCrossRef
103.
Humphries LL, et al. Hyperamylasemia in patients with eating disorders. Ann Intern Med. 1987;106(1):50–2.PubMedCrossRef
104.
105.
Chandra S, Gorospe EC, Leggett CL, Wang KK. Barrett’s esophagus in 2012: updates in pathogenesis, treatment, and surveillance. Curr Gastroenterol Rep. 2013;15(5):322.PubMedCrossRef
106.
Pacciardi B, Cargioli C, Mauri M. Barrett’s esophagus in anorexia nervosa: a case report. Int J Eat Disord. 2015;48(1):147–50.PubMedCrossRef
107.
Navab F, Avunduk C, Gang D, Frankel K. Bulimia nervosa complicated by Barrett’s esophagus and esophageal cancer. Gastrointest Endosc. 1996;44(4):492–4.PubMedCrossRef
108.
Dessureault S, Coppola D, Weitzner M, et al. Barrett’s esophagus and squamous cell carcinoma in a patient with psychogenic vomiting. Int J Gastrointest Cancer. 2002;32(1):57–61.PubMedCrossRef
109.
110.
Buyse S, Nahon S, Tuszynski T, Delas N. Bulimia nervosa as a risk factor for squamous cell carcinoma of the esophagus?. Am J Gastroenterol. 2003;98(6):1442–3.PubMedCrossRef
111.
Brewster DH, Nowell SL, Clark DN. Risk of oesophageal cancer among patients previously hospitalised with eating disorder. Cancer Epidemiol. 2015;39(3):313–20.PubMedCentralPubMedCrossRef
112.
Winstead NS, Willard SG. Gastrointestinal complaints in patients with eating disorders. J Clin Gastroenterol. 2006;40(8):678–82.PubMedCrossRef
113.
Roerig JL, Steffen KJ, Mitchell JE, Zunker C. Laxative abuse: epidemiology, diagnosis and management. Drugs. 2010;70(12):1487–503.PubMedCrossRef
114.
115.
Nusko G, Schneider B, Ernst H, et al. Melanosis coli–a harmless pigmentation or a precancerous condition?. Z Gastroenterol. 1997;35(5):313–8.PubMed
116.
117.
Weltzin TE, Bulik CM, McConaha CW, Kaye WH. Laxative withdrawal and anxiety in bulimia nervosa. Int J Eat Disord. 1995;17(2):141–6.PubMedCrossRef
Metadata
Title
Gastrointestinal symptoms and disorders in patients with eating disorders
Authors
Yasuhiro Sato
Shin Fukudo
Publication date
01-10-2015
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 5/2015
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-015-0611-x

Other articles of this Issue 5/2015

Clinical Journal of Gastroenterology 5/2015 Go to the issue

Case Report

A case of hepatic inflammatory pseudotumor protruding from the liver surface

Case Report

Endoscopic ultrasonography-guided drainage of infected intracystic papillary adenocarcinoma of the liver

Case Report

Successful endoscopic stent placement as a bridge to surgery for colonic obstruction induced by bevacizumab-based chemotherapy

Case Report

First case of bacteremia caused by Helicobacter cinaedi in a patient with liver cirrhosis: a case report and literature review

Case Report

Diffuse fatty metamorphosis of a large, well-differentiated hepatocellular carcinoma originating in the normal liver: a case report and literature review

Case Report

Spontaneous clearance of HCV accompanying hepatitis after liver transplantation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits